{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:19:28Z","timestamp":1758709168950},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,2,26]],"date-time":"2012-02-26T00:00:00Z","timestamp":1330214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00105-011-2274-y","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T09:33:07Z","timestamp":1341221587000},"page":"573-576","source":"Crossref","is-referenced-by-count":7,"title":["Remission eines iatrogenen Kaposi-Sarkoms bei Myasthenia gravis nach Umstellung der Immunsuppression auf den mTOR-Inhibitor Everolimus"],"prefix":"10.1007","volume":"63","author":[{"given":"S.","family":"Krengel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Satzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gutzmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,26]]},"reference":[{"key":"2274_CR1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5414\/CNP72420","volume":"72","author":"Atasoyu","year":"2009","unstructured":"Atasoyu EM, Bilgi O, Kinalp C et al (2009) Cutaneous Kaposi\u2019s sarcoma following immunosuppressive therapy for membranoproliferative glomerulonephritis. Clin Nephrol 72:420\u2013421","journal-title":"Clin Nephrol"},{"key":"2274_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-3062.2007.00239.x","volume":"10","author":"Babel","year":"2008","unstructured":"Babel N, Eibl N, Ulrich C et al (2008) Development of Kaposi\u2019s sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod. Transpl Infect Dis 10:59\u201362","journal-title":"Transpl Infect Dis"},{"key":"2274_CR3","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/archopht.1981.03930020481016","volume":"99","author":"Bedrick","year":"1981","unstructured":"Bedrick JJ, Savino PJ, Schatz NJ (1981) Conjunctival Kaposi\u2019s sarcoma in a patient with myasthenia gravis. Arch Ophthalmol 99:1607\u20131609","journal-title":"Arch Ophthalmol"},{"key":"2274_CR4","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.intimp.2006.09.018","volume":"6","author":"Boratynska","year":"2006","unstructured":"Boratynska M, Zmonarski SC, Klinger M (2006) Reccurence of Kaposi\u2019s sarcoma after increased exposure to sirolimus. Int Immunopharmacol 6:2018\u20132022","journal-title":"Int Immunopharmacol"},{"key":"2274_CR5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1091581810374654","volume":"29","author":"Bugelski","year":"2010","unstructured":"Bugelski PJ, Volk A, Walker MR et al (2010) Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia. Int J Toxicol 29:435\u2013466","journal-title":"Int J Toxicol"},{"key":"2274_CR6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/01.TP.0000115344.18025.0B","volume":"77","author":"Campistol","year":"2004","unstructured":"Campistol JM, Gutierrez-Dalmau A, Torregrosa JV (2004) Conversion to sirolimus: a successful treatment for posttransplantation Kaposi\u2019s sarcoma. Transplantation 77:760\u2013762","journal-title":"Transplantation"},{"key":"2274_CR7","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/ndt\/gfm089","volume":"22","author":"Campistol","year":"2007","unstructured":"Campistol JM, Schena FP (2007) Kaposi\u2019s sarcoma in renal transplant recipients \u2013 the impact of proliferation signal inhibitors. Nephrol Dial Transplant 22(Suppl 1):i17\u2013i22","journal-title":"Nephrol Dial Transplant"},{"key":"2274_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.transproceed.2009.11.017","volume":"42","author":"Chiurchiu","year":"2010","unstructured":"Chiurchiu C, Carreno CA, Schiavelli R et al (2010) Results of the conversion to everolimus in renal transplant recipients with posttransplantation malignancies. Transplant Proc 42:277\u2013279","journal-title":"Transplant Proc"},{"key":"2274_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","volume":"8","author":"Guba","year":"2002","unstructured":"Guba M, Breitenbuch P von, Steinbauer M et al (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8:128\u2013135","journal-title":"Nat Med"},{"key":"2274_CR10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/archderm.144.5.692","volume":"144","author":"Guenova","year":"2008","unstructured":"Guenova E, Metzler G, Hoetzenecker W et al (2008) Classic Mediterranean Kaposi\u2019s sarcoma regression with sirolimus treatment. Arch Dermatol 144:692\u2013693","journal-title":"Arch Dermatol"},{"key":"2274_CR11","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1016\/j.transproceed.2005.10.076","volume":"37","author":"Gutierrez-Dalmau","year":"2005","unstructured":"Gutierrez-Dalmau A, Sanchez-Fructuoso A, Sanz-Guajardo A et al (2005) Efficacy of conversion to sirolimus in posttransplantation Kaposi\u2019s sarcoma. Transplant Proc 37:3836\u20133838","journal-title":"Transplant Proc"},{"key":"2274_CR12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00296-004-0551-0","volume":"25","author":"Hoff","year":"2005","unstructured":"Hoff M, Rodevand E (2005) Development of multiple malignancies after immunosuppression in a patient with Wegener\u2019s granulomatosis. Rheumatol Int 25:238\u2013240","journal-title":"Rheumatol Int"},{"key":"2274_CR13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","volume":"80","author":"Kauffman","year":"2005","unstructured":"Kauffman HM, Cherikh WS, Cheng Y et al (2005) Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 80:883\u2013889","journal-title":"Transplantation"},{"key":"2274_CR14","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2006.01412.x","volume":"6","author":"Lebbe","year":"2006","unstructured":"Lebbe C, Euvrard S, Barrou B et al (2006) Sirolimus conversion for patients with posttransplant Kaposi\u2019s sarcoma. Am J Transplant 6:2164\u20132168","journal-title":"Am J Transplant"},{"key":"2274_CR15","first-page":"326","volume":"32","author":"Louthrenoo","year":"2003","unstructured":"Louthrenoo W, Kasitanon N, Mahanuphab P et al (2003) Kaposi\u2019s sarcoma in rheumatic diseases. Semin Arthritis Rheum 32:326\u2013333","journal-title":"Semin Arthritis Rheum"},{"key":"2274_CR16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.semarthrit.2006.11.001","volume":"36","author":"Mezalek","year":"2007","unstructured":"Mezalek ZT, Harmouche H, Attar NE et al (2007) Kaposi\u2019s sarcoma in association with Behcet\u2019s disease: case report and literature review. Semin Arthritis Rheum 36:328\u2013331","journal-title":"Semin Arthritis Rheum"},{"key":"2274_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/TP.0b013e318193886e","volume":"87","author":"Monaco","year":"2009","unstructured":"Monaco AP (2009) The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation 87:157\u2013163","journal-title":"Transplantation"},{"key":"2274_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000277613","volume":"220","author":"Nassar","year":"2010","unstructured":"Nassar D, Schartz NE, Bouche C et al (2010) Kaposi\u2019s sarcoma after long-acting steroids: time until remission and drug washout. Dermatology 220:159\u2013163","journal-title":"Dermatology"},{"key":"2274_CR19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archderm.144.5.654","volume":"144","author":"Saggar","year":"2008","unstructured":"Saggar S, Zeichner JA, Brown TT et al (2008) Kaposi\u2019s sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris. Arch Dermatol 144:654\u2013657","journal-title":"Arch Dermatol"},{"key":"2274_CR20","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.transproceed.2006.08.063","volume":"38","author":"Sanchez-Fructuoso","year":"2006","unstructured":"Sanchez-Fructuoso A, Conesa J, Perez F et al (2006) Conversion to sirolimus in renal transplant patients with tumors. Transplant Proc 38:2451\u20132452","journal-title":"Transplant Proc"},{"key":"2274_CR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","volume":"87","author":"Schena","year":"2009","unstructured":"Schena FP, Pascoe MD, Alberu J et al (2009) Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation 87:233\u2013242","journal-title":"Transplantation"},{"key":"2274_CR22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archderm.1982.01650240064026","volume":"118","author":"Snyder","year":"1982","unstructured":"Snyder RA, Schwartz RA (1982) Telangiectatic Kaposi\u2019s sarcoma. Occurrence in a patient with thymoma and myasthenia gravis receiving long-term immunosuppressive therapy. Arch Dermatol 118:1020\u20131021","journal-title":"Arch Dermatol"},{"key":"2274_CR23","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","volume":"352","author":"Stallone","year":"2005","unstructured":"Stallone G, Schena A, Infante B et al (2005) Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients. N Engl J Med 352:1317\u20131323","journal-title":"N Engl J Med"},{"key":"2274_CR24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/DCR.0b013e318197217f","volume":"52","author":"Svrcek","year":"2009","unstructured":"Svrcek M, Tiret E, Bennis M et al (2009) KSHV\/HHV8-associated intestinal Kaposi\u2019s sarcoma in patient with ulcerative colitis receiving immunosuppressive drugs: report of a case. Dis Colon Rectum 52:154\u2013158","journal-title":"Dis Colon Rectum"},{"key":"2274_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.healun.2007.03.010","volume":"26","author":"Valantine","year":"2007","unstructured":"Valantine H (2007) Is there a role for proliferation signal\/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. J Heart Lung Transplant 26:557\u2013564","journal-title":"J Heart Lung Transplant"},{"key":"2274_CR26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1610-0387.2008.06712.x","volume":"6","author":"Vogt","year":"2008","unstructured":"Vogt T, Brockmeyer N, Kutzner H, Schofer H (2008) Short German guidelines: angiosarcoma and Kaposi sarcoma. J Dtsch Dermatol Ges 6(Suppl 1):19\u201324","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-011-2274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-011-2274-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-011-2274-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:37:55Z","timestamp":1558582675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-011-2274-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,26]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1007\/s00105-011-2274-y","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,26]]}}}